NCT05982522 2026-03-27
IN10018 Combination Therapy in Previously-treated Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Withdrawn
InxMed (Shanghai) Co., Ltd.
Partner Therapeutics, Inc.
Genfleet Therapeutics (Shanghai) Inc.
NantPharma, LLC
Celgene
PTS International Inc.